SCHEMBL2869337

SCHEMBL2869337

CCCCCCCCCCCC(N)=O.O=C(O)CC(C(=O)O)S(=O)(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
SOAT1 P35610 2/20 0.45
FAAH O00519 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
GPR84 Q9NQS5 8/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octadecanoic Acid Amide SCHEMBL28678843 1.00 MEN1 (0.45) MEN1KMT2ASOAT1FAAHTP53
Ammonia Solution, Strong SCHEMBL28661833 0.98 MEN1 (0.44) MEN1KMT2ASOAT1FAAHTP53
Oleamide SCHEMBL25222681 0.92 FAAH (0.60) MEN1KMT2ASOAT1FAAHTP53
Oleamide SCHEMBL28400601 0.91 FAAH (0.59) MEN1KMT2ASOAT1FAAHTP53
Dodecanoate SCHEMBL4654045 0.90 GPR84 (0.57) MEN1KMT2ACYP1A2CYP2C19GPR84
Stearic Acid SCHEMBL28399582 0.90 GPR84 (0.57) MEN1KMT2ACYP1A2CYP2C19GPR84
Dodecane SCHEMBL27762128 0.90 GPR84 (0.48) MEN1KMT2AGPR84PPARGPPARD
Tridecane SCHEMBL27760783 0.90 GPR84 (0.48) MEN1KMT2AGPR84PPARGPPARD
Octane SCHEMBL27438093 0.90 GPR84 (0.48) MEN1KMT2AGPR84PPARGPPARD
Stearic Acid SCHEMBL28352791 0.89 GPR84 (0.55) MEN1KMT2ACYP1A2CYP2C19GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812192-B2 PARTIALLY OR COMPLETELY NEUTRALIZED FATTY ACIDS; NON-BETAINE AMPHOTERIC SURFACTANT; AND A SULPHOSUCCINATE-TYPE ANIONIC SURFACTANT L'OREAL S.A. (FR) 2004-11-02 US claimed
US-20030224955-A1 Foaming cosmetic compositions, uses for cleansing or make-up removal L'OREAL S.A. (FR) 2003-12-04 US claimed
US-12496265-B2 Foaming aqueous composition comprising spiculisporic acid, an alkyl polyglycoside and a polysaccharide L'OREAL (FR) 2025-12-16 US disclosed
US-12296039-B2 Composition with long-lasting concealing effects L'OREAL (FR) 2025-05-13 US disclosed
US-12186418-B2 Foaming composition L'OREAL (FR) 2025-01-07 US disclosed
US-20240374496-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2024-11-14 US disclosed
EP-3149137-B2 FOAMING CLEANSER OREAL (FR) 2024-10-09 EP disclosed
EP-4408379-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2024-08-07 EP disclosed
EP-3435962-B1 DEVICE FOR APPLYING A COMPOSITION IN THE FORM OF AN EMULSION COMPRISING A FILM-FORMING AGENT AND NON-VOLATILE OILS OREAL (FR) 2024-05-22 EP disclosed
EP-3435963-B1 EMULSION COMPRISING A FILM-FORMING AGENT AND NON-VOLATILE OILS AND COSMETIC PROCESS OREAL (FR) 2024-05-01 EP disclosed
US-20240024221-A1 COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS L'OREAL (FR) 2024-01-25 US disclosed
US-6821942-B2 A FOAMING SURFACTANT, HYDROPHOBIC SILICA AND OXYALKYLENATED COMPOUNDS L'OREAL (FR) 2004-11-23 US disclosed
US-6812192-B2 PARTIALLY OR COMPLETELY NEUTRALIZED FATTY ACIDS; NON-BETAINE AMPHOTERIC SURFACTANT; AND A SULPHOSUCCINATE-TYPE ANIONIC SURFACTANT L'OREAL S.A. (FR) 2004-11-02 US disclosed
US-20030224955-A1 Foaming cosmetic compositions, uses for cleansing or make-up removal L'OREAL S.A. (FR) 2003-12-04 US disclosed
US-20030194425-A1 Moist cleansing, skin care or cosmetic article L'OREAL (FR) 2003-10-16 US disclosed
EP-1352950-A2 Moist cleaning, skin care or cosmetic article L'OREAL (FR) 2003-10-15 EP disclosed
US-20030053979-A1 Iridescent cosmetic composition and uses thereof L'OREAL (FR) 2003-03-20 US disclosed
US-20030021817-A1 Iridescent cosmetic composition and uses thereof L'OREAL (FR) 2003-01-30 US disclosed
US-20020039976-A1 Cosmetic cleansing composition L' OREAL (FR) 2002-04-04 US disclosed
US-20020035047-A1 Cleansing cosmetic composition L' OREAL (FR) 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035047-A1 Cleansing cosmetic composition SGMS1, SGMS2, CUTA MEN1 2935/4885KMT2A 2691/4885SOAT1 30/4885
US-20240374496-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS KRT18, DSG1, KRTCAP2 MEN1 4484/4885KMT2A 1612/4885SOAT1 369/4885
US-20240024221-A1 COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS KRT18, LMNB2, LMNB1 MEN1 4073/4885KMT2A 2691/4885SOAT1 3002/4885
US-12296039-B2 Composition with long-lasting concealing effects KRT18, MUC1, MMAB MEN1 636/4885KMT2A 1270/4885SOAT1 2588/4885
US-20030021817-A1 Iridescent cosmetic composition and uses thereof INCENP, LAGE3, CUTA MEN1 440/4885KMT2A 3524/4885SOAT1 3286/4885
US-20020039976-A1 Cosmetic cleansing composition SGMS1, SGMS2, CUTA MEN1 2929/4885KMT2A 2681/4885SOAT1 43/4885
US-12186418-B2 Foaming composition SGMS1, SGMS2, DEGS1 MEN1 1604/4885KMT2A 4322/4885SOAT1 315/4885
US-12496265-B2 Foaming aqueous composition comprising spiculisporic acid, an alkyl polyglycoside and a polysaccharide KRT18, SMURF1, SPG11 MEN1 4537/4885KMT2A 2789/4885SOAT1 1567/4885
US-20030224955-A1 Foaming cosmetic compositions, uses for cleansing or make-up removal CUTA, DSG1, DEGS1 MEN1 1546/4885KMT2A 1451/4885SOAT1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.